Literature DB >> 32406565

SCAI guidelines on device selection in Aorto-Iliac arterial interventions.

Dmitriy N Feldman1, Ehrin J Armstrong2, Herbert D Aronow3, Subhash Banerjee4, Larry J Díaz-Sandoval5, Michael R Jaff6, Sasanka Jayasuriya7, Safi U Khan8, Andrew J Klein9, Sahil A Parikh10, Kenneth Rosenfield11, Mehdi H Shishehbor12, Rajesh V Swaminathan13, Christopher J White14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32406565      PMCID： PMC7578005          DOI： 10.1002/ccd.28947

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  54 in total

1.  Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

Review 2.  SCAI appropriate use criteria for peripheral arterial interventions: An update.

Authors:  Andrew J Klein; Michael R Jaff; Bruce H Gray; Herbert D Aronow; Robert M Bersin; Larry J Diaz-Sandoval; Robert S Dieter; Douglas E Drachman; Dmitriy N Feldman; Osvaldo S Gigliotti; Kamal Gupta; Sahil A Parikh; Duane S Pinto; Mehdi H Shishehbor; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2017-06-05       Impact factor: 2.692

3.  Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II.

Authors:  Marianne Brodmann; Martin Werner; Andrew Holden; Gunnar Tepe; Dierk Scheinert; Arne Schwindt; Florian Wolf; Michael Jaff; Alexandra Lansky; Thomas Zeller
Journal:  Catheter Cardiovasc Interv       Date:  2018-11-25       Impact factor: 2.692

4.  Contemporary outcomes after endovascular treatment for aorto-iliac artery disease.

Authors:  Yoshimitsu Soga; Osamu Iida; Daizo Kawasaki; Yasutaka Yamauchi; Kenji Suzuki; Keisuke Hirano; Ryoji Koshida; Daisuke Kamoi; Junichi Tazaki; Michiaki Higashitani; Yoshiaki Shintani; Terutoshi Yamaoka; Shinya Okazaki; Nobuhiro Suematsu; Taketsugu Tsuchiya; Yusuke Miyashita; Norihiko Shinozaki; Hiroki Takahashi
Journal:  Circ J       Date:  2012-08-02       Impact factor: 2.993

5.  Transluminal angioplasty of complete iliac obstructions.

Authors:  R F Colapinto; R D Stronell; W K Johnston
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959

6.  Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease.

Authors:  Kim Taeymans; Erik Groot Jebbink; Suzanne Holewijn; Jasper M Martens; Michel Versluis; Peter C J M Goverde; Michel M P J Reijnen
Journal:  J Vasc Surg       Date:  2017-11-21       Impact factor: 4.268

7.  Editor's Choice - Outcomes of Self Expanding PTFE Covered Stent Versus Bare Metal Stent for Chronic Iliac Artery Occlusion in Matched Cohorts Using Propensity Score Modelling.

Authors:  M Piazza; F Squizzato; A Dall'Antonia; S Lepidi; M Menegolo; F Grego; M Antonello
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-05-06       Impact factor: 7.069

Review 8.  Angioplasty versus stenting for iliac artery lesions.

Authors:  Joost Bekken; Hidde Jongsma; Ninos Ayez; Cornelis J Hoogewerf; Vincent Van Weel; Bram Fioole
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

9.  Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Authors:  Michael D Dake; Gary M Ansel; Michael R Jaff; Takao Ohki; Richard R Saxon; H Bob Smouse; Thomas Zeller; Gary S Roubin; Mark W Burket; Yazan Khatib; Scott A Snyder; Anthony O Ragheb; J King White; Lindsay S Machan
Journal:  Circ Cardiovasc Interv       Date:  2011-09-27       Impact factor: 6.546

10.  Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Panagiotis Kitrou; Miltiadis Krokidis; Dimitrios Karnabatidis
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501
View more
  4 in total

1.  Comparison of BARD®LIFESTREAM™ covered balloon-expandable stent versus GORE® VIABAHN™ covered self-expandable stent in treatment of aortoiliac obstructive disease: study protocol for a prospective randomized controlled trial (NEONATAL trial).

Authors:  Yuhan Qi; Jiarong Wang; Jichun Zhao; Bing Huang; Fei Xiong; Xiaojiong Du; Xiyang Chen; Qiang Guo; Tiehao Wang; Ding Yuan
Journal:  Trials       Date:  2022-05-12       Impact factor: 2.728

2.  Long-term results of endovascular reconstruction for aortoiliac occlusive disease.

Authors:  Min Yang; Bihui Zhang; Guochen Niu; Ziguang Yan; Xiaoqiang Tong; Yinghua Zou
Journal:  Quant Imaging Med Surg       Date:  2021-04

Review 3.  [Endovascular Revascularization for Aortoiliac Occlusive Disease].

Authors:  Myungsu Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-28

4.  Evidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease.

Authors:  Osamu Iida; Mitsuyoshi Takahara; Toshiaki Mano
Journal:  J Atheroscler Thromb       Date:  2021-06-02       Impact factor: 4.928
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.